Quest Diagnostics, GE Healthcare and Synchron were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Quest Diagnostics (NYSE:DGX) recently made headlines with its strategic collaboration with Google Cloud, aimed at revolutionizing data management through advanced analytics and AI technologies, ...

Quest Diagnostics (DGX) announced a collaboration with Google (GOOG) Cloud to streamline Quest’s data management, improve data analytics, and ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

Quest said it aims through the collaboration to streamline data management, improve data analytics, and personalize the experiences of its patients.

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate complex tasks.

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

Medicare covers many of the tests performed at Quest Diagnostics, as long they’re medically necessary, and the Quest facility you’re using accepts Medicare. Quest Diagnostics is one of the ...

This was the stock's third consecutive day of losses.